Skip to main content

Basic Mechanisms of Kynurenine Actions in the Central Nervous System

  • Chapter
Recent Advances in Tryptophan Research

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 398))

Abstract

The kynurenine pathway represents the major biochemical route for the metabolism of L-tryptophan in mammals. The pathway is particularly important in the central nervous system (CNS), since the ‘precursor responsiveness’ of the pathway exceeds that of tryptophan metabolism via 5-hydroxytryptamine (Freese et al. 1990; Stone, 1993).. Any procedure which alters the systemic availability of tryptophan will therefore have important consequences for CNS function. In particular, it is now well established that within the CNS, the kynurenine pathway lead to the formation of two compounds — quinolinic acid and kynurenic acid — with activity at receptors for neurotransmitter amino acids.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Beal, M.F., Ferrante, R.J., Swartz, K.J. and Kowall, N.W., 1991, Chronic quinolinic acid lesions in rats closely resemble Huntington’s disease. J. Neurosci.11:1649.

    CAS  Google Scholar 

  • Beal, M.F., Swartz, K.J., Finn, S.F., Mazurek, M.F and Kowall, N.W., 1991, Neurochemical characterization of excitotoxin lesions in the cerebral cortex. J. Neurosci.11:147.

    CAS  Google Scholar 

  • Beal., M.F., Kowall, N.K., Swartz, K.J., Ferrante, R.J. and Martin, J.B., 1988, Systemic approaches to modifying quinolinic acid striatal lesions in rats. J. Neurosci.8:3901.

    CAS  Google Scholar 

  • Boegman, R.J., El-Defraqy, S.R., Jhamandas, K., Beninger, R.J. and Ludwin, S.K., 1985, Quinolinic acid neurotoxicity in the nucleus basalis antagonized by kynurenic acid. Neurobiol. Aging, 6:331.

    Article  CAS  Google Scholar 

  • Brady, R.J. and Swann, J.W., 1988, Suppression of ictal-like activity by kynurenic acid does not correlate with its efficacy as an NMDA receptor antagonist, Epilepsy Res. 2:232.

    Article  CAS  Google Scholar 

  • Burton, N.R., Smith, D.A.S. and Stone, T.W., 1988, A quantitative pharmacological analysis of some excitatory amino acid receptors in mouse neocortex, Brit. J. Pharmacol.93:693.

    CAS  Google Scholar 

  • Chen, J., Graham, S., Moroni, F. and Simon, R., 1993, A study of the dose dependency of a glycine receptor antagonist in focal ischemia, J. Pharm. exp. Ther, 267:937.

    CAS  Google Scholar 

  • Chizhmakov, I.V., Kiskin, N.I., Tsyndrenko, A.Y. and Krishtal, O. A., 1990, Desensitisation of NMD A receptors does not proceed in the absence of kynurenate. Neurosci. Lett.108:88.

    Article  CAS  Google Scholar 

  • Davies, S.W. and Roberts, P.J., 1987, No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid. Nature, 327:326.

    Article  CAS  Google Scholar 

  • Dixon, D.B. and Copenhagen, D.R., 1992, Suppression of a calcium current by CNQX and kynurenate. Neurosci. Lett.147:147.

    Article  CAS  Google Scholar 

  • Figueredocardenas, G., Anderson, K.D.., Chen, Q., Veenman, C.L. and Reiner, A., 1994, Relative survival of striatal projection neurons and interneurones after intrastriatal injection of quinolinic acid in rats. Exp. Neurol.129:37.

    Article  CAS  Google Scholar 

  • Forloni, G.L, Angeretti, N., Rizzi, M. and Vezzani, A., 1992, Chronic infusion of quinolic acid in rat striatum:effects on discrete neuronal populations. J. Neurol. Sci.108:129.

    Article  CAS  Google Scholar 

  • Freese, A., Swartz, K.J., During, M.J. and Martin, J.B., 1990, Kynurenine metabolites of tryptophan:implications for neurologic diseases. Neurology40:691.

    CAS  Google Scholar 

  • Germano,I.M., Pitts, L.H., Meldrum, B.S., Bartkowski, H.M. and Simon, R.P., 1987, Kynurenate inhibition of cell excitation decreases stroke size and deficits. Ann. Neurol.22:730.

    Article  CAS  Google Scholar 

  • Ghribi, O., Callebert, J., Plotkine, M. and Boulu, R.G., 1994, Effect of kynurenic acid on the ischaemia-induced accumulation of glutamate in rat striatum. Neuroreport5:435.

    Article  CAS  Google Scholar 

  • Henderson, G., Johnson, J.W. and Ascher, P., 1990, Competitive antagonists and partial agonists at the glycine modulatory site of the mouse NMDA receptor., J. Physiol430:189.

    CAS  Google Scholar 

  • Heyes, M.P., Jordan,E.K., Lee, K., Saito, K., Frank, J.A., Snoy, P. J., Markey, S.P. and Gravell, M., 1992, Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to CSF quinolinic acid and kynurenic acid. Brain Res., 570:237.

    Article  CAS  Google Scholar 

  • Hicks, R.R., Smith, D.H., Gennarelli, T.A. and Mcintosh, T., 1994, Kynurenate is neuroprotective following experimental brain injury in the rat, Brain Res. 655:91.

    Article  CAS  Google Scholar 

  • Huang, Q., Zhou, D., Sapp, E., Aizawa, H., Ge, P., Bird, E.D., Vonsattel, J.-P. and DiFiglia, M., 1995, Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington’s disease. Neurosci. 65:397.

    Article  CAS  Google Scholar 

  • Ignatowicz, E., Vezzani, A.M., Rizzi, M. and D’lncalci, M., 1991, Nerve cell death induced in vivo by kainic acid and quinolinic acid does not involve apoptosis. Neuroreport, 2:651.

    Article  CAS  Google Scholar 

  • Jauch, D.A., Sethy, V.H., Weick, B.G., Chase, T.N. and Schwarcz, R.,1993, Intravenous administration of L-kynurenine to rhesus monkeys:effects on quinolinate and kynurenate levels in serum and CSF. Neuropharmacology 32:467.

    Article  CAS  Google Scholar 

  • Leeson, P.D. and Iversen, L.L., 1994, The glycine site on the NMDA receptor:structure-activity relationships and therapeutic potential. J. Med. Chem., 37:4053.

    Article  CAS  Google Scholar 

  • McLarnon, J.G. and Curry, K., 1990, Quinolinate activation of NMDA ion channels in rat hippocampal neurons. Neurosci. Lett.116:341.

    Article  CAS  Google Scholar 

  • Nozaki, K. and Beal, M.F., 1992, Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats. J. Cereb. Blood Flow Metab., 12:400.

    Article  CAS  Google Scholar 

  • Perkins, M.N. and Stone, T.W., 1982, An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res. 247:184.

    Article  CAS  Google Scholar 

  • Popoli, P., Pexxola, A., Domenici, M.R., Sagratella, S., Diana, G., Caporali, M.G., Bronzetti, E., Vega, J. and Scotti de Carolis, A., 1994, Behavioural and electrophysiological correlates of the quinolinic acid rat model of Huntington’s disease in rats. Brain Res. Bull., 35:329.

    Article  CAS  Google Scholar 

  • Pullan, L.M. and Cler, J. A., 1989, Schild plot analysis of glycine and kynurenic acid at the NMDA excitatory amino acid receptor, Brain Res. 497:59.

    Article  CAS  Google Scholar 

  • Reinhard, J.F.jnr., Erickson, J.B. and Flanagan, E.M., 1994, Quinolinic acid in neurological disease:opportunities for novel drug discovery. Adv. Pharmacol.30:85.

    Article  CAS  Google Scholar 

  • Russi, P., Carla, V. and Moroni, F., 1989, Indolepyruvic acid administration increases the brain content of kynurenic acid. Is this a new avenue to modulate excitatory amino acid receptors in vivo? Biochem. Pharmacol.38:2405.

    Article  CAS  Google Scholar 

  • Stone, T.W., 1993, Neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Revs.45:309

    CAS  Google Scholar 

  • Stone, T.W., 1988, Comparison of kynurenic acid and 2-APV suppression of epileptiform activity in rat hippocampal slices. Neurosci. Lett.84:234.

    Article  CAS  Google Scholar 

  • Stone, T.W., 1991, Kynurenine and glycine enhance neuronal sensitivity to NMDA. Life Sci., 48:765.

    Article  CAS  Google Scholar 

  • Stone, T. W. and Burton, N.R., 1988, NMD A receptors and their endogenous ligands in vertebrate CNS. Progr. Neurobiol.30:333.

    Article  CAS  Google Scholar 

  • Stone, T.W. and Perkins, M.N., 1988, Quinolinic acid:a potent endogenous excitant at amino acid receptors. Europ. J. Pharmacol.72:411.

    Article  Google Scholar 

  • Swartz, K.A., During, M.J., Freese., A. and Beal, M.F., 1990, Cerebral synthesis and release of kynurenate:an endogenous antagonist of excitatory amino acid receptors. J. Neurosci. 10:2965.

    CAS  Google Scholar 

  • Williams, T.L., Smith, D.A.S., Burton, N.R. and Stone, T.W., 1988, Amino acid phamacology in neocortical slices:evidence for bimolecular actions from an extension of the Hill and Gaddum-Schild equations. Brit. J. Phamacol. 95:805

    CAS  Google Scholar 

  • Wood, E.R., Bussey, T.J. and Phillips, A.G., 1993, A glycine antagonist 7-chlorokynurenic acid attenuates ischemia-induced learning deficits. Neuroreport4:151.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Plenum Press, New York

About this chapter

Cite this chapter

Stone, T.W., MacGregor, D.G., Smith, R.A., Jones, P., Behan, W.M.H., Graham, D.I. (1996). Basic Mechanisms of Kynurenine Actions in the Central Nervous System. In: Filippini, G.A., Costa, C.V.L., Bertazzo, A. (eds) Recent Advances in Tryptophan Research. Advances in Experimental Medicine and Biology, vol 398. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0381-7_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0381-7_32

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-8026-9

  • Online ISBN: 978-1-4613-0381-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics